Genetic Factors in Parkinsons Disease and Potential Therapeutic Targets
Journal:
Current Neuropharmacology
Volume:
1
Page:
301-313
Author(s):
Jian Feng
Genetic Polymorphism of Organic Anion and Cation Transporters: Pharmacokinetic and Pharmacodynamic Consequences in Pharmacotherapy
Journal:
Current Pharmacogenomics
Volume:
1
Page:
245-257
Author(s):
Hiroshi Takane, Ichiro Ieiri and Kenji Otsubo
Aspects of the Stability and Bioavailability of Carbohydrates and Carbohydrate Derivatives
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
3
Page:
633-649
Author(s):
N. B. Drinnan and Frank Vari
Coenzyme Q10 in Neurodegenerative Diseases
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
1917-1921
Author(s):
Clifford W. Shults
Immunophilins in Nervous System Degeneration and Regeneration
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
1376-1382
Author(s):
M. Avramut and C. L. Achim
Serotonin Control of Dopaminergic Neurotransmission: Focus on 5-HT2 Receptors
Journal:
Current Neuropharmacology
Volume:
1
Page:
153-164
Author(s):
Vincenzo Di Matteo and Ennio Esposito
Gene and Cancer Therapy - Pseudorabies Virus: A Novel Research and Therapeutic Tool?
Journal:
Current Gene Therapy
Volume:
3
Page:
155-182
Author(s):
Zsolt Boldogkoi and Antal Nogradi
Biochemical and Therapeutic Effects of Antioxidants in the Treatment of Alzheimers Disease, Parkinsons Disease, and Amyotrophic Lateral Sclerosis
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
2
Page:
95-107
Author(s):
Vincenzo Di Matteo and Ennio Esposito
The Abuse Liability and Therapeutic Potential of Drugs Evaluated for Cocaine Addiction as Predicted by Animal Models
Journal:
Current Neuropharmacology
Volume:
1
Page:
21-46
Author(s):
Joshua A. Lile and Michael A. Nader
Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
643-671
Author(s):
Robert R. Luedtke and Robert H. Mach